These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11098087)

  • 1. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.
    Liou MJ; Lin JD; Chan EC; Liu FH; Chao TC; Weng HF
    Cancer Lett; 2000 Nov; 160(1):75-80. PubMed ID: 11098087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues.
    Lin JD; Chan EC; Chao TC; Chen KT; Hsueh C; Ho YS; Weng HF
    Ann Oncol; 2000 May; 11(5):625-9. PubMed ID: 10907960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
    Lin JD; Hsueh C; Chao TC; Weng HF
    Endocr Pathol; 2001; 12(1):15-21. PubMed ID: 11478264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
    Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
    Ryu KY; Senokozlieff ME; Smanik PA; Wong MG; Siperstein AE; Duh QY; Clark OH; Mazzaferri EL; Jhiang SM
    Thyroid; 1999 Apr; 9(4):405-9. PubMed ID: 10319949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
    Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
    Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.
    Arturi F; Russo D; Giuffrida D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2000 Nov; 143(5):623-7. PubMed ID: 11078986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
    Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
    Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
    Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
    Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
    J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas.
    Russo D; Manole D; Arturi F; Suarez HG; Schlumberger M; Filetti S; Derwahl M
    Thyroid; 2001 Jan; 11(1):37-9. PubMed ID: 11272095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
    Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
    Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
    Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.